# CAtheter-Based Ablation of Atrial Fibrillation Compared to Conventional Treatment in Patients With Heart Failure With Preserved Ejection Fraction

Study · id `cardio:ct-nct05508256` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05508256](<https://clinicaltrials.gov/study/NCT05508256>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05508256

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems; Heart failure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1548 participants.

## Technical summary

Registry record NCT05508256. Randomized; no masking; primary purpose treatment. Start 2023-03 (anticipated); primary completion 2026-07 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 1548 participants (planned count; ClinicalTrials.gov record NCT05508256, source copy `cardio:ctgov-nct05508256-2023-03-06`, retrieved 2026-10-26)
- Planned start: 2023-03 (anticipated) (ClinicalTrials.gov record NCT05508256, source copy `cardio:ctgov-nct05508256-2023-03-06`, retrieved 2026-10-26)
- Primary completion: 2026-07 (anticipated) (ClinicalTrials.gov record NCT05508256, source copy `cardio:ctgov-nct05508256-2023-03-06`, retrieved 2026-10-26)
- Completion: 2027-07 (anticipated) (ClinicalTrials.gov record NCT05508256, source copy `cardio:ctgov-nct05508256-2023-03-06`, retrieved 2026-10-26)
- Countries: Germany (ClinicalTrials.gov record NCT05508256, source copy `cardio:ctgov-nct05508256-2023-03-06`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05508256-2023-03-06`, retrieved 2026-10-26)

## The registry's words

- Brief title: CAtheter-Based Ablation of Atrial Fibrillation Compared to Conventional Treatment in Patients With Heart Failure With Preserved Ejection Fraction
- Acronym: CABA-HFPEF
- Condition: Atrial Fibrillation
- Condition: Heart Failure With Preserved Ejection Fraction
- Condition: Heart Failure With Mildly Reduced Ejection Fraction
- Intervention (Device): CE-marked Catheter Ablation
- Lead sponsor: Charite University, Berlin, Germany
- Lead sponsor class: OTHER
- Collaborator: Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)
- Collaborator class: OTHER
- Collaborator: Kompetenznetz Vorhofflimmern e.V. (AFNET)
- Collaborator class: UNKNOWN
- Collaborator: Boston Scientific Corporation
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition term reads as this condition, and the trial is coded with its broader condition: Heart failure with mildly reduced or preserved ejection fraction (`cardio:hfpef`)
- Registry lists this organization as the lead sponsor: Charite University, Berlin, Germany (`cardio:org-charite-university-berlin-germany`)
- Registry lists this organization as a collaborator: Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) (`cardio:org-deutsches-zentrum-fur-herz-kreislauf-forschung-dzhk`)
- Registry lists this organization as a collaborator: Boston Scientific (`cardio:boston-scientific`)

## Provenance

Content hash: 17ba17bead8cabd12382b712c3024095c95bd5ad64904f614380aa5e3a3f8de4
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
